Taiwan Cell Manufacturing Co., Ltd. (tcmc) will showcase its advanced cell and gene therapy capabilities at BioJapan 2026 in Yokohama, Japan, from October 7–9. We invite global biotech, pharma, and regenerative medicine leaders to connect with us at Booth C-01.
Our Core Focus:
- GMP & CDMO Solutions: Scalable, end-to-end contract manufacturing.
- Cell & Gene Therapy (CGT): Cutting-edge solutions for next-gen therapeutics.
- CAR-T & Lentiviral Vector (LV): High-yield, cost-efficient viral vector and cell production platforms.
Partner with tcmc
We look forward to exploring cross-border collaborations and discussing how tcmc can accelerate your CGT pipeline from development to commercialization. Visit Booth C-01 to meet our executive team.
Exhibition Information
- Event: BioJapan 2026 (Co-located with Regenerative Medicine Japan & healthTECH JAPAN)
- Dates: Oct 7 (Wed) – Oct 9 (Fri), 2026 | 10:00 – 17:00
- Venue: PACIFICO Yokohama, Japan
- tcmc Booth: Exhibition Hall C, C-01
- Highlights: GMP | CDMO | CGT | CAR-T | Lentiviral Vector (LV)
- Official Website: BioJapan 2026 Official Website
